Lewis H Titterton jr
CIK 1499254 · Chief Executive Officer · last filed 2026-09-25
Lewis H Titterton jr is a Chief Executive Officer who has filed 106 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider bought $131.9K of ANIX on Sep 25, 2026. Across all open-market trades the lifetime net is +$1.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ANIX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SARATOGA SPRINGS, NY 12866
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIX | Director | 1,046,003 | $2.90 | $3.03M | $1.78M | 55 | 2026-09-25 |
| Anixa Biosciences Inc (ITUS) Delisted | Director | 839,544 | — | — | -$519.0K | 16 | 2018-09-17 |
Recent Filings
106 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-25 | ANIX | Buy (P) | +49,036 | $131.9K | EDGAR |
| 2026-09-14 | ANIX | Buy (P) | +10,000 | $27.3K | EDGAR |
| 2026-07-20 | ANIX | Buy (P) | +12,000 | $41.6K | EDGAR |
| 2026-07-16 | ANIX | Buy (P) | +2,797 | $9.2K | EDGAR |
| 2026-06-17 | ANIX | Buy (P) | +2,836 | $7.5K | EDGAR |
| 2026-01-26 | — | Grant (A) | — | $0 | |
| 2026-01-06 | ANIX | Grant (A) | — | $0 | EDGAR |
| 2025-12-16 | ANIX | Exer (M) | +16,000 | $46.7K | EDGAR |
| 2025-11-18 | — | Buy (P) | +4,761,905 | $1.00M | |
| 2025-10-07 | — | Exer (M) | +800,000 | $149.5K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.